Q-Line Biotech IPO Live Subscription Status

Real-time subscription data from BSE & NSE with category-wise breakdowns

📈 Building steadily
📈 GMP Today 🎟️ Allotment Status 📄 Full IPO Details Listed at NSE · Registrar: Purva Sharegistry (India) Pvt.Limited.
Listed SME
Price: ₹326 - ₹343 Lot: 800 Min: ₹2,74,400 Period: 21 May - 25 May
Subscribed
102.48x
Total Demand
₹14,618 Cr
Applications
2,35,591
Subscription (Shares)
CategoryOfferedAppliedTimes
QIB 11,88,000 14,72,37,200 123.94
NII 8,91,600 13,04,65,600 146.33
bNII (>10 Lakh) 5,94,400 10,62,89,200 178.82
sNII (2-10 Lakh) 2,97,200 2,41,76,400 81.35
Retail 20,79,200 14,84,91,200 71.42
TOTAL 41,58,800 42,61,94,000 102.48
Application Breakup
CategoryReservedApplicationsTimes
NII 1,114 49,780 44.69
bNII (>10 Lakh) 743 31,162 41.94
sNII (2-10 Lakh) 372 18,618 50.05
Retail 2,599 1,85,614 71.42
TOTAL 4,828 2,35,591 48.80
Subscription (Crores)
CategoryOfferedDemandTimes
QIB 40.75 5,050.24 123.94
NII 30.58 4,474.97 146.33
bNII (>10 Lakh) 20.39 3,645.72 178.82
sNII (2-10 Lakh) 10.19 829.25 81.35
Retail 71.32 5,093.25 71.42
TOTAL 142.65 14,618.45 102.48
Subscription by Category 1× = fully subscribed · capped 10×
QIB
123.94x
NII
146.33x
bNII (>10 Lakh)
178.82x
sNII (2-10 Lakh)
81.35x
Retail
71.42x
Estimated Allotment Chance
Retail 1.6% (71.42x subscribed)
Low chance
S-HNI (2-10L) 1.2% (81.35x subscribed)
Low chance
B-HNI (>10L) 2.2% (178.82x subscribed)
Low chance
If 100 retail investors apply, approximately 2 will get allotment.
Estimated from current subscription data, calibrated against published basis-of-allotment results. Actual allotment depends on the number of applications received and SEBI's allotment rules — draw of lots for Retail, Employee and NII; proportionate for QIB.
Disclaimer: Subscription data is sourced from BSE and NSE. Please verify with official exchange websites before making any investment decisions. This information is for educational purposes only and should not be construed as investment advice.

Q-Line Biotech IPO Subscription — Detailed Analysis

Where Q-Line Biotech Subscription Stands Today

Q-Line Biotech IPO has been subscribed 102.48 times overall — a heavily oversubscribed level that signals strong investor demand and improves the prospects of a positive listing day. A total of 2,35,591 applications have been received so far.

Q-Line Biotech IPO Subscription — FAQs

Q-Line Biotech IPO is currently subscribed 102.48 times overall.

Q-Line Biotech IPO is open for subscription from May 21, 2026 to May 25, 2026.

The price band for Q-Line Biotech IPO is ₹326 - ₹343 per share.

New to subscription data? The hub explains what QIB, NII and Retail mean and how to read the table. For allotment odds from these numbers, see the allotment chances calculator or our IPO allotment process explainer.

GMP Update